Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019002612) SYNBIOTIC COMPOSITION FOR PREVENTING METABOLIC DISORDERS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/002612 International Application No.: PCT/EP2018/067712
Publication Date: 03.01.2019 International Filing Date: 29.06.2018
IPC:
A61K 35/745 (2015.01) ,A61K 9/00 (2006.01) ,A61K 31/715 (2006.01) ,A23L 33/00 (2016.01) ,A23L 33/135 (2016.01) ,A23L 33/21 (2016.01) ,A61P 3/06 (2006.01)
[IPC code unknown for A61K 35/745]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
[IPC code unknown for A23L 33][IPC code unknown for A23L 33/135][IPC code unknown for A23L 33/21]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
06
Antihyperlipidemics
Applicants:
N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186 2712 HM Zoetermeer, NL
Inventors:
ENGELS, Eefje; NL
VAN LIMPT, Cornelus Johannes Petrus; NL
OOSTING, Annemarie; NL
OOZEER, Akhtar Raish; NL
KNOL, Jan; NL
MISCHKE, Mona; NL
Agent:
NEDERLANDSCH OCTROOIBUREAU; P.O. Box 29720 2502 LS The Hague, NL
Priority Data:
17179124.730.06.2017EP
Title (EN) SYNBIOTIC COMPOSITION FOR PREVENTING METABOLIC DISORDERS
(FR) COMPOSITION SYMBIOTIQUE POUR LA PRÉVENTION DE TROUBLES MÉTABOLIQUES
Abstract:
(EN) The invention relates toimproved liver health and lipidmetabolism later in life upon ingestion of synbiotics early in life.
(FR) L’invention concerne une amélioration de la santé du foie et du métabolisme des lipides plus tard dans la vie lors de l'ingestion de symbiotiques en début de vie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)